Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40762485	s-gbmab	— (—)	3261	4038	100.00%	Distribution not available
40762485	s-gbmab	u/ml (u/ml)	35	132	24.24%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Renal failure

1417

880

15.09

307.65

1.3

1.2

45.17

—

u/ml

—

Acute renal failure

724

403

19.29

307.65

1.4

1.1

50.80

—

u/ml

—

Chronic kidney disease

1054

600

18.46

307.65

1.4

1.1

45.17

—

u/ml

—

Nephropathy related operations

396

338

12.62

307.65

1.7

1.1

45.17

—

u/ml

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

319

27.76

307.65

1.3

1.2

—

u/ml

—

All chronic kidney diseases

1441

860

14.34

307.65

1.3

1.2

42.60

—

u/ml

—

Dialysis, with operation codes

417

229

19.65

307.65

1.7

1.1

45.17

—

u/ml

—

Other necrotizing vasculopathies

260

186

15.28

288.17

3.4

1.1

42.60

—

u/ml

—

ILD, hospital admissions 3, with pneumonia sepsis

247

185

14.27

265.74

1.3

1.1

—

u/ml

—

Secondary hypertension

197

102

20.10

251.94

1.3

1.1

—

u/ml

—

Other necrotizing vasculopathies (FG)

214

143

16.30

246.10

2.7

1.1

—

u/ml

—

Nephrotic syndrome

130

19.33

161.56

1.2

1.1

—

u/ml

—

Other disorders involving the immune mechanism, not elsewhere classified

133

18.12

160.04

1.2

1.1

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

130

18.74

158.70

1.2

1.1

—

Diabetic nephropathy, excluding more controls

273

384

6.07

141.68

1.1

1.2

—

u/ml

—

Second line medication for Crohn's disease

562

1811

3.14

134.67

1.8

1.2

—

30.21

u/ml

—

L04AX Other immunosuppressants

547

1755

3.15

132.07

1.8

1.2

—

30.21

u/ml

—

Wegener granulomatosis

27.56

126.53

4.6

1.1

—

u/ml

—

IgA nephropathy (IgA glomerulonephritis)

103

16.74

118.77

1.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

224

248

6.34

113.99

1.1

1.3

—

u/ml

—

Chronic nephritic syndrome

114

12.37

112.18

1.2

1.1

—

u/ml

—

Microscopic polyangiitis

67.39

109.73

2.0

1.1

—

u/ml

—

Hypertensive heart and/or renal disease

272

425

4.85

109.05

1.2

—

u/ml

—

Non-ischemic cardiomyopathy

327

688

3.89

102.14

1.2

1.1

—

u/ml

—

Oedema, not elsewhere classified

309

813

3.80

99.55

1.1

1.2

—

u/ml

—

ILD-related respiratory insufficiency

12.82

94.50

1.6

1.2

—

u/ml

—

Implicit fungal Sepsis

115

136

8.78

90.13

1.6

1.1

—

u/ml

—

Disorders resulting from impaired renal tubular function

100

10.37

84.88

1.6

1.2

—

u/ml

—

Gout, strict definition

237

595

4.08

83.92

1.2

1.1

—

u/ml

—

Pneumonia due to other infectious organisms, not elsewhere classified

12.82

82.01

1.8

1.1

—

u/ml

—

Hypertensive Renal Disease

13.16

81.66

1.1

—

u/ml

—

Isolated proteinuria

12.07

79.42

1.2

1.1

—

u/ml

—

Implicit fungal Sepsis

10.95

78.67

1.8

1.2

—

u/ml

—

Fungal Sepsis

10.41

77.84

1.8

1.2

—

u/ml

—

Abnormal findings on examination of urine, without diagnosis

118

8.65

74.56

1.4

1.2

—

u/ml

—

Idiopathic pulmonary fibrosis

125

202

6.41

74.23

1.2

1.1

—

u/ml

—

Pneumocystosis

13.90

71.96

1.8

1.1

—

u/ml

—

Pleural effusion

187

445

4.29

71.17

1.2

1.1

—

u/ml

—

Anaemia in chronic diseases classified elsewhere

12.15

70.77

1.3

1.1

—

Hyperkalaemia

129

7.88

70.33

1.1

—

u/ml

—

Tramadol

572

1545

2.29

66.18

1.1

1.3

—

65.20

u/ml

—

Other disorders of skin and subcutaneous tissue

534

2132

2.24

64.05

1.3

1.2

—

38.80

u/ml

—

Protozoal diseases

9.38

60.25

1.8

1.1

—

u/ml

—

Enlarged lymph nodes

145

332

4.43

57.95

1.1

—

u/ml

—

Explicit bacterial Sepsis

114

217

5.36

56.86

1.2

—

u/ml

—

Respiratory disorders in diseases classified elsewhere

15.76

56.09

4.1

1.0

—

u/ml

—

Other nutritional deficiencies

460

1986

2.19

53.19

1.1

1.3

—

31.25

u/ml

—

Hypertensive Heart Disease

183

399

3.63

52.08

1.3

1.2

—

Streptococcal septicaemia

100

185

5.52

51.55

1.2

1.1

—

u/ml

—

Other specified/unspecified necrotizing vasculopathies

15.83

50.81

2.4

1.1

—

Diabetic maculopathy, excluding more controls

122

273

4.56

50.37

1.1

—

Undetermined asthma, excluding more controls

186

5.39

50.01

1.2

1.1

—

u/ml

—

Other soft tissue disorders, not elsewhere classified

629

1876

1.97

49.83

1.2

1.3

—

49.07

u/ml

—

Type 1 diabetes, wide definition, subgroup 1

179

530

3.41

49.67

1.1

1.3

—

Later onset COPD, excluding more controls

166

345

3.76

49.43

1.1

—

u/ml

—

Isolated proteinuria with specified morphological lesion

18.09

49.35

1.0

1.1

—

u/ml

—

Disorders of mineral metabolism

185

5.36

48.39

1.2

1.1

—

Obesity due to excess calories

338

1425

2.39

48.38

1.1

1.2

—

34.10

u/ml

—

Other acute lower respiratory infections

399

1723

2.22

47.73

1.4

1.2

—

75.40

u/ml

—

Other and unspecified vasculitis limited to skin

8.98

47.30

1.5

1.1

—

u/ml

—

Vasculitis limited to skin, not elsewhere classified

8.52

46.97

1.5

1.1

—

u/ml

—

Obesity

428

1945

2.14

46.55

1.1

1.3

—

31.25

u/ml

—

Type 1 diabetes, wide definition

182

568

3.24

46.42

1.1

1.3

—

Disorders of calcium metabolism

136

6.11

46.32

1.2

1.1

—

Obesity and other hyperalimentation

428

1953

2.12

45.88

1.1

1.3

—

31.25

u/ml

—

Codeine

588

1646

1.95

44.19

1.2

1.3

—

65.20

u/ml

—

Respiratory insufficiency

132

6.00

43.98

1.1

—

u/ml

—

Other diseases of pericardium

7.55

43.83

1.2

1.0

—

u/ml

—

Hyperlipidaemia, other/unspecified

282

1078

2.43

41.18

1.3

1.2

—

u/ml

—

Sleep apnoea, including avohilmo

644

2226

1.80

39.22

1.1

1.3

—

32.42

u/ml

—

Polymyalgia rheumatica

125

346

3.67

38.72

1.3

1.1

—

Codeine or tramadol medication

719

2267

1.74

38.20

1.2

1.3

—

45.94

u/ml

—

Hypokalaemia

105

260

4.10

38.06

1.1

—

u/ml

—

Syncope and collapse

289

1079

2.31

37.23

1.1

1.2

—

u/ml

—

Iron deficiency anaemia secondary to blood loss (chronic)

144

452

3.23

36.64

1.2

—

u/ml

—

Polyarteritis nodosa and related conditions

10.49

36.08

1.5

1.1

—

Symptoms and signs concerning food and fluid intake

204

4.42

35.62

1.3

1.1

—

u/ml

—

Hydronephrosis

201

4.44

35.46

1.1

—

u/ml

—

Idiopathic gout

107

284

3.85

35.36

1.1

—

u/ml

—

Acute nephritic syndrome

9.07

35.18

1.5

1.1

—

Giant cell arteritis

6.35

34.93

1.2

1.1

—

Nerve, nerve root and plexus disorders

675

2427

1.71

34.54

1.3

1.2

—

50.07

u/ml

—

Hypersensitivity angiitis

56.47

34.47

8.0

1.1

42.60

—

u/ml

—

Allergic purpura

7.10

34.13

1.2

—

Biguanides

593

2056

1.77

33.87

1.1

1.3

—

58.40

u/ml

—

Non-allergic asthma (mode), excluding more controls

104

276

3.76

33.62

1.3

1.1

—

u/ml

—

Hypothyroidism, drug reimbursement

110

5.11

33.30

1.1

1.4

—

Other CVD (FINNGEN)

121

4.99

32.75

1.1

1.2

—

u/ml

—

Hernia of abdominal wall, postoperative

118

351

3.39

32.72

1.5

1.1

—

u/ml

—

Other pleural conditions

264

3.81

32.47

1.2

1.1

—

u/ml

—

Hypo-osmolality and hyponatraemia

131

420

3.14

31.86

1.2

1.1

—

u/ml

—

Other disorders of white blood cells

155

4.70

30.46

1.2

—

Other specific joint derangements/joint disorders

427

1475

1.88

30.27

1.2

1.3

—

55.75

—

Adult respiratory distress syndrome

10.63

28.56

1.3

1.1

—

u/ml

—

Pain, not elsewhere classified

164

644

2.56

27.63

1.1

1.2

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

148

4.59

27.45

1.1

—

Cardiomyopathy

126

434

2.93

27.41

1.4

1.1

—

u/ml

—

Infections of the skin and subcutaneous tissue

366

1978

1.84

26.48

1.2

1.3

—

53.44

u/ml

—

Soft tissue disorders

600

1894

1.64

25.28

1.1

1.3

—

53.44

u/ml

—

Episodal and paroxysmal disorders

634

2009

1.61

25.05

1.2

1.3

—

39.42

u/ml

—

Insulin, fast-acting (human)

104

339

3.10

24.97

1.1

1.3

—

u/ml

—

Multiple myeloma and malignant plasma cell neoplasms

132

4.59

24.63

1.2

1.1

—

Cardiac arrest

5.58

24.44

1.1

1.3

—

Viral hepatitis, IBD co-morbidity

7.37

24.18

1.2

1.1

—

Adrenocortical insufficiency

5.49

24.12

1.3

1.1

—

Multiple myeloma, including Hilmo

123

4.67

23.91

1.2

—

Gout due to impairment of renal function

9.43

23.60

1.1

—

Charcot foot

9.14

23.45

1.1

1.4

—

COPD-related respiratory insufficiency

104

355

2.97

23.13

1.1

—

Other disorders of adrenal gland

113

4.71

22.49

1.3

1.2

—

Multiple myeloma

6.11

22.28

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

6.11

22.28

1.2

—

Myocarditis

6.52

22.19

1.3

1.1

—

Hypocalcemia

6.41

22.07

1.3

1.1

—

Other specified/unspecified systemic involvement of connective tissue

120

4.50

21.77

1.2

1.1

—

Pain in joint

352

1257

1.79

21.68

1.2

1.3

—

62.70

—

Emphysema

187

3.70

21.48

1.1

—

u/ml

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

18.08

21.41

1.2

1.1

—

Mixed connective tissue disease

153

3.99

21.11

1.2

1.1

—

Neurological diseases

467

1413

1.67

21.07

1.2

1.3

—

39.42

u/ml

—

Other and unspecified drugs and medicaments

215

3.45

20.80

1.1

—

Other/unspecified cytomegaloviral diseases

6.74

20.63

1.5

1.1

—

Eosinophilic disease (BM)

20.99

20.57

1.2

1.1

—

Intracranial trauma

303

1173

1.82

20.17

1.1

1.4

—

39.42

u/ml

—

Cytomegaloviral disease

5.92

19.90

1.4

1.1

—

Drug-induced adrenocortical insufficiency

6.87

19.73

1.3

1.0

—

Pericarditis

5.39

19.73

1.5

1.0

—

u/ml

—

Disorders of gallbladder, biliary tract and pancreas

572

2358

1.53

19.37

1.1

1.3

—

34.10

u/ml

—

Weight loss

287

3.00

19.36

1.3

1.1

—

u/ml

—

Acute sinusitis

287

1481

1.80

19.34

1.4

1.2

—

34.10

u/ml

—

Cytomegalovirus infection, IBD co-morbidity

5.74

19.28

1.4

1.1

—

Infection due to other mycobacteria

8.19

19.28

1.2

1.0

—

Other infectious diseases

257

3.12

19.19

1.6

1.1

—

Other joint disorders

467

1526

1.62

19.16

1.1

1.3

—

55.75

u/ml

—

Disorders of synovium and tendon

303

1506

1.77

19.06

1.2

1.4

—

31.25

u/ml

—

Familial hypercholesterolemia

102

388

2.65

18.56

1.1

1.2

—

u/ml

—

Temporal arteritis

4.89

18.55

1.1

1.0

—

Drug-induced osteoporosis with pathological fracture

7.41

18.37

1.1

1.0

—

Eosinophilia

6.36

18.29

1.2

1.1

—

Cardiomyopathies, Primary/intrinsic

281

2.95

18.18

1.1

—

u/ml

—

Arthropathies in other diseases classified elsewhere

4.77

18.05

1.0

1.1

—

Acidosis

6.65

18.03

1.1

1.3

—

Disorders of sclera, cornea, iris and ciliary body

322

1903

1.70

17.95

1.3

1.2

—

65.20

u/ml

—

Secondary right heart disease

109

4.31

17.92

1.2

1.1

—

u/ml

—

Diabetic maculopathy

120

473

2.42

17.76

1.1

1.2

—

Cardiomyopathy (excluding other)

297

2.86

17.61

1.1

—

u/ml

—

Suppurative and necrotic conditions of lower respiratory tract

152

3.69

17.34

1.2

—

u/ml

—

Short Achilles tendon (acquired)

5.75

17.34

1.3

1.2

—

Exposure to unspecified factor

562

2714

1.49

17.31

1.2

1.3

—

50.17

u/ml

—

Concussion

257

1166

1.80

17.16

1.1

1.4

—

39.42

u/ml

—

Substance abuse, excluding more controls

334

1713

1.67

17.00

1.1

1.3

—

46.92

u/ml

—

Low back pain

420

1907

1.59

16.96

1.1

1.3

—

47.58

u/ml

—

Dorsalgia

549

1956

1.51

16.70

1.2

1.3

—

47.58

u/ml

—

Giant cell arteritis with polymyalgia rheumatica

4.47

16.68

1.1

1.0

—

Other infectious diseases

221

3.12

16.61

1.8

1.1

—

Abnormal weight loss

265

2.91

16.41

1.1

—

u/ml

—

Other pulmonary heart/vessel disease

127

3.86

16.14

1.2

1.1

—

u/ml

—

Scleritis and episcleritis

136

3.73

16.13

1.5

1.1

—

Problems related to lifestyle

257

2.91

16.07

1.1

—

u/ml

—

Hypercalcemia

119

3.95

15.98

1.2

1.1

—

Other complications of surgical and medical care, not elsewhere classified

260

2.88

15.76

1.1

1.3

—

Acquired haemolytic anaemia

5.07

15.08

1.1

—

Other abnormalities of plasma proteins

7.01

14.96

1.1

—

u/ml

—

Disorders of skin appendages

258

1510

1.71

14.95

1.2

1.3

—

38.79

—

Pulmonary oedema

6.09

14.87

1.2

1.1

—

Decubitus ulcer and pressure area

164

3.34

14.79

1.2

1.1

—

Amyloidosis

5.93

14.53

1.0

1.3

—

357

2007

1.57

14.44

1.1

1.3

—

61.60

u/ml

—

Respiratory conditions due to other external agents

5.68

14.39

1.7

1.1

—

Thrombocytopenia, unspecified

193

3.10

14.31

1.2

1.1

—

u/ml

—

Non-follicular lymphoma

282

2.69

14.12

1.3

1.1

—

u/ml

—

Pulmonary eosinophilia, not elsewhere classified

12.62

13.75

1.1

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

209

2.96

13.67

1.2

1.1

—

u/ml

—

Pneumonia due to Streptococcus pneumoniae

4.28

13.65

1.4

1.1

—

Recurrent and persistent haematuria

13.66

13.63

1.1

—

Shoulder lesions

412

1646

1.52

13.53

1.3

—

65.20

u/ml

—

Cirrhosis of liver, NAS

164

3.23

13.46

1.2

—

Neoplasms

392

1352

1.54

13.29

1.2

1.3

—

58.42

u/ml

—

Other and unspecified disorders of white blood cells

112

3.73

13.23

1.2

—

Thrombotic microangiopathy

16.74

12.88

5.5

1.1

—

Episcleritis

114

3.65

12.88

1.1

—

Nonischemic cardiomyopathy

261

2.67

12.83

1.1

—

Thiazolidinediones

314

2.51

12.81

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

526

2523

1.42

12.73

1.1

1.3

—

45.94

u/ml

—

Acute peritonitis

180

3.04

12.73

1.3

1.1

—

Substance abuse

334

2039

1.54

12.70

1.1

1.3

—

61.60

u/ml

—

Injuries to the head

598

2639

1.40

12.68

1.2

1.3

—

50.17

u/ml

—

Tularaemia

6.41

12.57

1.1

—

Mental and behavioural disorders due to psychoactive substance use

341

2072

1.53

12.41

1.1

1.3

—

61.60

u/ml

—

Familial hypercholesterolemia, with ischemic heart disease

267

2.61

12.32

1.1

—

u/ml

—

Chronic apical periodontitis

605

2499

1.38

11.93

1.2

1.3

—

49.07

u/ml

—

Tularaemia

5.04

11.76

1.1

1.2

—

Pyogenic arthritis

173

2.98

11.68

1.1

—

Haemolytic anaemias

3.71

11.55

1.1

—

Pyothorax

123

3.39

11.54

1.3

1.2

—

u/ml

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

22.24

11.41

1.3

1.0

—

Other/unspecified rheumatoid arthritis

351

2.33

11.36

1.1

—

Sicca syndrome [Sjögren]

193

2.83

11.26

1.1

—

u/ml

—

Tubulo-interstitial nephritis, not specified as acute or chronic

107

3.49

10.98

1.2

1.1

—

Fibromyalgia

182

2.82

10.68

1.2

1.3

—

u/ml

—

Rapidly progressive nephritic syndrome

27.25

10.62

1.8

1.2

—

Small fibre neuropathy

3.76

10.47

1.2

1.1

—

Infective dermatitis

314

2.34

10.45

1.1

—

Carpal tunnel syndrome

307

1806

1.50

10.31

1.2

—

38.80

u/ml

—

Amyloidosis, other/unspecified

5.39

10.17

1.0

1.3

—

Diseases of peritoneum

288

2.38

10.10

1.2

1.1

—

Certain zoonotic bacterial diseases

4.72

10.06

1.1

—

Cardiomyopathy, other and unspecified

166

2.86

10.06

1.8

1.0

—

Lupus nephritis

21.91

10.01

1.0

—

Chorioretinal inflammation

4.10

10.00

1.4

1.1

—

Erythema nodosum

4.20

9.93

1.1

1.0

—

Constipation

471

2358

1.39

9.90

1.1

1.3

—

35.17

u/ml

—

Viral pneumonia (known virus, not influenza)

4.05

9.82

1.4

1.2

—

Pruritus

268

2.41

9.75

1.1

—

Certain zoonotic bacterial diseases

3.73

9.75

1.1

—

Kela reimbursement Agammaglobulinemia (D80-84)

8.82

9.71

1.3

1.2

—

Polyarteritis nodosa

12.04

9.71

1.5

1.1

—

Spondylopathies (FG)

313

2.28

9.62

1.2

1.1

—

Pure hyperglyceridaemia

4.76

9.33

1.1

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

243

2.44

9.33

1.7

1.2

—

Asthma mixed form (mode), excluding more controls

3.97

9.31

1.1

—

Polyarthritis, unspecified

3.68

9.29

1.2

1.1

—

Crohn's disease NAS

152

2.86

9.22

1.2

—

Arterial embolism and thrombosis

158

2.82

9.17

1.1

—

Infection of intervertebral disc (pyogenic)

4.93

9.14

1.4

—

Asthma mixed form (mode)

3.91

9.13

1.1

—

Benign neoplasms

505

2052

1.36

9.10

1.2

1.3

—

58.42

u/ml

—

Atypical mycobacterium lung infection

7.06

8.95

1.1

—

Drug-induced cataract

3.99

8.92

1.5

1.1

—

u/ml

—

Henoch-Schönlein purpura nephritis (HSPN)

15.40

8.91

1.3

1.8

—

Dizziness and giddiness

393

2238

1.39

8.86

1.1

1.3

—

30.21

u/ml

—

Amputation of foot

3.73

8.77

1.2

—

Myelodysplastic syndrome, including Hilmo

3.71

8.75

1.3

1.2

—

u/ml

—

Later onset COPD

172

832

1.66

8.68

1.1

1.2

—

u/ml

—

Other diseases of stomach and duodenum

170

2.68

8.55

1.3

1.1

—

u/ml

—

Other metabolic disorders

272

2.29

8.55

1.7

1.2

—

Intracranial injury

305

2006

1.44

8.50

1.1

1.3

—

65.33

u/ml

—

Etanercept

148

2.80

8.49

1.1

—

Hypersensitivity pneumonitis due to organic dust

4.41

8.46

1.2

1.1

—

Rotator cuff syndrome

311

1548

1.44

8.43

1.3

—

65.20

u/ml

—

Dermatitis due to substances taken internally

138

2.86

8.39

1.9

1.2

—

Other specified disorders of kidney and ureter

3.43

8.38

1.1

1.2

—

Other obstructive and reflux uropathy

3.60

8.13

1.1

1.2

—

Extreme obesity with alveolar hypoventilation

3.21

8.10

1.0

1.2

—

u/ml

—

Discitis, unspecified

4.23

8.05

1.0

1.3

—

Other specified/unspecified inflammatory spondylopathies

104

3.11

7.99

1.3

1.1

—

Acute generalized exanthematous pustulosis

115

2.99

7.94

2.1

1.1

—

Arterial embolism and thrombosis of lower extremity artery

3.34

7.81

1.1

1.2

—

Disorder of lipoprotein metabolism, unspecified

329

2.11

7.80

1.5

1.1

—

Other diseases of upper respiratory tract

575

2303

1.30

7.80

1.4

1.2

—

40.07

u/ml

—

3.71

7.78

1.1

1.2

—

Cholangitis (primary sclerosing, PSC)

167

2.60

7.77

1.2

1.1

—

Status post-ami

147

672

1.67

7.77

1.1

—

u/ml

—

Congenital iodine-deficiency syndrome/hypothyroidism

3.69

7.76

1.0

—

Late syphilis

4.45

7.75

1.1

—

Membranous nephropathy

12.82

7.74

1.0

1.1

—

Vascular disorders of the intestines

186

2.50

7.65

1.1

—

u/ml

—

Non-Hodgkin lymphoma, all

118

2.92

7.61

1.1

1.2

—

Generalized skin eruption due to drugs and medicaments

102

3.08

7.61

2.2

1.1

—

Cholelithiasis, broad definition with cholecystitis

433

2179

1.34

7.49

1.1

1.3

—

34.10

u/ml

—

Tobacco use

136

2.75

7.45

1.1

—

Allergic bronchopulmonary aspergillosis (ABPA)

16.81

7.35

1.5

1.0

—

u/ml

—

Acquired absence of limb

7.55

7.27

1.1

—

Juvenile arthritis (FINNGEN)

3.32

7.25

1.1

1.3

—

Diffuse large B-cell lymphoma, including Hilmo

133

2.74

7.21

1.1

1.2

—

Diffuse large B-cell lymphoma

133

2.74

7.21

1.1

1.2

—

Diffuse large B-cell lymphoma, helper endpoint

133

2.74

7.21

1.1

1.2

—

Acute drug-induced interstitial lung disorder

9.15

7.14

2.4

1.1

—

Sequelae of other external causes

146

2.63

7.05

1.2

1.1

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

14.91

7.03

1.2

1.0

—

Retinal vascular occlusion

357

2.00

7.01

1.1

—

u/ml

—

Retinal vascular disorders

365

1.99

6.95

1.1

—

u/ml

—

Congenital malformations of the urinary system

153

2.57

6.94

1.2

—

Systemic sclerosis (FG)

4.15

6.84

2.1

1.0

—

Other aneurysm

150

2.56

6.70

1.2

1.1

—

Abscess of lung

4.10

6.67

1.1

—

Tuberculosis

169

2.45

6.60

1.3

1.1

—

u/ml

—

Congenital malformations of the urinary system

163

2.48

6.60

1.2

—

Amputation of ankle bones

3.50

6.60

1.2

1.1

—

Ulcer of oesophagus

182

2.38

6.54

1.2

1.1

—

Convalescence

118

2.74

6.44

1.3

1.2

—

Late syphilis

3.81

6.41

1.1

—

Other conditions related to polyarteritis nodosa

19.74

6.40

1.8

1.2

—

Ocular pain

190

2.33

6.40

1.1

—

Cholelithiasis

409

2148

1.31

6.33

1.1

1.3

—

34.10

u/ml

—

Mixed hyperlipidaemia

3.12

6.33

1.0

1.2

—

Crohn's disease of large intestine

120

2.69

6.25

1.2

1.1

—

Biological medicines for asthma

4.02

6.19

1.3

1.1

—

Failure and rejection of transplanted organs and tissues

4.21

6.13

1.3

1.1

—

Other abnormal immunological findings in serum

3.81

6.11

1.1

1.0

—

Systemic sclerosis

3.81

6.11

2.1

1.0

—

Nummular dermatitis

233

2.16

6.09

1.4

1.1

—

u/ml

—

Causalgia

5.26

6.05

1.1

—

Vitamin B12 deficiency anaemia

301

2.01

6.02

1.1

—

Left bundle-branch block

152

2.45

6.02

1.2

1.0

—

Vascular diseases of the intestine

100

2.83

6.00

1.2

—

u/ml

—

Total colectomy

106

2.77

5.97

1.1

—

Total colectomy operation

106

2.77

5.97

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

445

2267

1.29

5.95

1.1

1.3

—

31.25

u/ml

—

Systemic sclerosis, icd10

3.73

5.94

2.1

1.1

—

Lymphoid leukaemia

172

2.35

5.92

1.1

1.2

—

Hypothyroidism, other/unspecified

430

2189

1.29

5.91

1.1

1.3

—

31.25

u/ml

—

Other and unspecified vascular occlusions

284

2.02

5.85

1.1

—

u/ml

—

Intestinal malabsorption

113

2.68

5.84

1.1

—

Duodenal ulcer

312

1.97

5.81

1.2

1.1

—

u/ml

—

Pneumonia derived septicemia

2.82

5.75

1.4

1.1

—

Occupational exposure to risk-factors

103

2.76

5.71

1.4

1.2

—

u/ml

—

Oesophageal varices

103

2.75

5.71

1.2

—

u/ml

—

Chronic hepatitis, not elsewhere classified

3.00

5.70

1.1

—

Collagenous colitis

253

2.07

5.70

1.1

—

Abnormalities of gait and mobility

371

1.87

5.68

1.1

—

u/ml

—

Disorders of the thyroid gland

462

2363

1.27

5.67

1.1

1.3

—

49.07

u/ml

—

Other disorders of iris and ciliary body

3.14

5.64

1.0

1.1

—

Monoarthritis, not elsewhere classified

2.78

5.64

1.1

—

Algoneurodystrophy

3.13

5.63

1.0

1.2

—

Childhood asthma (age<16), excluding more controls

126

2.38

5.59

1.0

1.1

—

Rare circulating lymphoid malignancy, including Hilmo

3.03

5.55

1.0

1.3

—

Hidradenitis suppurativa

3.02

5.54

1.1

1.2

—

Paralytic strabismus

203

2.19

5.53

1.1

—

Chronic lymphocytic leukaemia, helper endpoint

3.10

5.51

1.0

1.2

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

3.10

5.51

1.0

1.2

—

Chronic lymphocytic leukaemia

3.10

5.51

1.0

1.2

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

123

2.53

5.45

1.1

1.4

—

Nonalcoholic steatohepatitis

6.41

5.44

1.0

—

Dermatopolymyositis (FG)

5.72

5.40

1.0

1.1

—

Dependence on enabling machines and devices, not elsewhere classified

6.32

5.40

1.5

1.1

—

Other mycoses, not elsewhere classified/unspecified

11.97

5.38

1.3

1.0

—

Pneumonitis due to solids and liquids

232

2.08

5.37

1.0

1.1

—

Malignant neoplasm, wide definition for exclusion

421

1927

1.28

5.37

1.1

1.3

—

65.20

u/ml

—

Presbycusis

418

1.79

5.35

1.1

—

u/ml

—

Other meningitis

4.80

5.33

1.3

1.1

—

Cystic kidney disease

2.86

5.26

1.0

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

210

1488

1.40

5.26

1.3

—

45.17

u/ml

—

Psoriatic and enteropathic arthropathies

268

1.99

5.25

1.1

—

Aspergillosis

5.38

5.14

1.4

1.1

—

u/ml

—

Explicit fungal Sepsis

6.58

5.14

1.3

1.1

—

8.77

5.13

1.4

1.1

—

Unspecified contracted kidney

8.68

5.12

1.1

—

Abdominal aortic aneurysm (AAA)

303

1.91

5.11

1.2

1.1

—

Unspecified misadventure during surgical and medical care

159

2.29

5.06

1.1

—

Rosacea

307

1.90

5.05

1.4

1.3

—

Other juvenile arthritis

2.92

5.04

1.1

1.4

—

Vitamin deficiency, wide

117

2.50

4.96

1.1

1.2

—

Vitamin deficiency

117

2.50

4.96

1.1

1.2

—

Third [oculomotor] nerve palsy

3.54

4.92

1.1

—

ILD and respiratory illness in diseases classified elsewhere

8.05

4.91

1.4

1.1

—

Fracture of lower leg, including ankle

259

1918

1.34

4.91

1.1

1.3

—

35.17

u/ml

—

Malignant neoplasm of bladder, including Hilmo

417

1.75

4.88

1.3

1.2

—

u/ml

—

Visual impairment including blindness (binocular or monocular)

181

2.17

4.87

1.1

—

Artificial opening status

137

2.36

4.83

1.0

1.1

—

u/ml

—

Other renal tubulo-interstitial diseases

4.26

4.83

1.1

—

Juvenile rheumatoid arthirtis

3.61

4.78

1.1

1.2

—

Postmenopausal osteoporosis with pathological fracture

138

2.34

4.76

1.1

—

Pneumococcal septicemia

2.64

4.74

1.4

1.1

—

Other epidermal thickening

120

2.44

4.73

1.4

1.2

—

u/ml

—

Folate deficiency anaemia

5.15

4.68

1.0

1.1

—

Trigeminal neuralgia

127

2.38

4.65

1.1

—

Chronic iridocyclitis

115

2.46

4.63

1.2

—

Disorders of oesophagus in diseases classified elsewhere

3.26

4.63

1.5

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

385

2054

1.27

4.63

1.1

1.3

—

31.25

u/ml

—

Primary hyperparathyroidism

310

1.85

4.61

1.2

1.1

—

u/ml

—

Injuries to the ankle and foot

315

2170

1.29

4.59

1.1

1.3

—

53.44

u/ml

—

Drug-induced osteoporosis

4.63

4.59

1.1

—

u/ml

—

Cystic kidney disease

2.64

4.57

1.0

1.1

—

Malignant neoplasm of endocrine gland

186

2.11

4.57

1.2

—

Visual field defects

234

1.98

4.54

1.2

1.1

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

5.98

4.49

1.1

—

Primary adrenocortical insufficiency

4.76

4.40

1.2

1.1

—

Benign neoplasm: Descending colon

203

2.04

4.38

1.1

—

Cyst of kidney

203

2.04

4.38

1.1

—

Other nonautoimmune haemolytic anaemias

12.77

4.37

1.0

1.2

—

Dermatopolymyositis

4.33

4.35

1.0

1.1

—

Hypoparathyroidism

2.61

4.32

1.0

—

Erythema multiforme

2.99

4.30

1.3

1.0

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

4.60

4.28

1.0

1.5

—

Pleural plaque

289

1.85

4.28

1.3

1.1

—

u/ml

—

Artificial joint operation, meniscal resection

451

2378

1.23

4.27

1.2

1.3

—

65.20

u/ml

—

Other secondary coxarthrosis

2.65

4.24

1.2

1.1

—

Amenorrhoea

108

2.42

4.22

1.2

1.5

—

Other localized connective tissue disorders

3.46

4.20

1.3

1.2

—

Blindness, monocular

5.38

4.17

1.1

—

Malignant immunoproliferative diseases

4.46

4.17

1.1

—

Disorders of magnesium metabolism

6.06

4.17

1.3

1.2

—

Injuries to the elbow and forearm

320

2216

1.27

4.15

1.3

—

50.17

u/ml

—

Benign neoplasm: Ascending colon

442

1.66

4.11

1.2

1.1

—

Osteomyelitis of vertebra

10.53

4.06

1.1

—

Psoriasis (vulgaris), strict definition

2.58

4.06

1.4

1.1

—

Other and unspecified rosacea

216

1.96

4.05

1.5

1.3

—

Mental and behavioural disorders due to opioids

2.52

4.05

1.0

1.1

—

Synovial cyst of popliteal space [Baker]

175

2.07

4.05

1.2

1.1

—

Scleritis

4.28

4.04

2.6

1.1

—

Other nonthrombocytopenic purpura

5.13

4.03

1.0

1.1

—

Other overlap syndromes

4.26

4.03

1.2

1.1

—

Drug-induced systemic lupus erythematosus

6.63

4.02

1.0

1.1

—

Gingival hyperplasia

2.50

3.97

1.6

1.2

—

Other disorders of optic [2nd] nerve and visual pathways

170

2.07

3.96

1.1

1.2

—

Respiratory tuberculosis

151

2.13

3.90

1.3

1.1

—

u/ml

—

Respiratory tuberculosis, confirmed and not-confirmed

151

2.13

3.90

1.3

1.1

—

u/ml

—

Anosmia

6.29

3.90

1.4

1.1

—

Haemophagocytic lymphohistiocytosis

13.39

3.87

1.2

1.0

—

Calcinosis cutis

12.98

3.84

1.7

1.2

—

Myeloproliferative diseases

235

1.88

3.82

1.1

—

Personal history of other diseases and conditions

214

1.91

3.76

1.1

1.3

—

Bursitis of shoulder

2.94

3.75

1.1

—

Malignant neoplasm of renal pelvis, including Hilmo

4.23

3.73

2.6

1.4

—

Moderate visual impairment, binocular

2.59

3.73

1.1

—

Behavioural disorders, excluding more controls

3.62

3.70

1.0

1.3

—

Tuberculosis, IBD comorbidity

196

1.95

3.67

1.3

1.1

—

u/ml

—

Myositis

2.72

3.67

1.2

1.4

—

Iron deficiency

3.53

3.61

1.0

1.2

—

Melanocytic naevi of lower limb, including hip

104

2.33

3.60

1.1

—

Open wound of head

262

1983

1.28

3.59

1.3

—

75.40

u/ml

—

Other diseases of biliary tract

233

1.86

3.59

1.2

1.1

—

Conduct disorder

2.97

3.58

1.0

1.4

—

Hypoplasia of dental enamel

4.85

3.56

1.9

1.8

—

Other and unspecified injuries of shoulder and upper arm

2.59

3.56

1.1

1.2

—

u/ml

—

Idiopathic thrombocytopenic purpura

2.53

3.56

1.4

1.1

—

Haemolytic-uraemic syndrome

10.60

3.55

1.0

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

5.41

3.53

1.0

—

Malignant neoplasm of thyroid gland, including Hilmo

192

1.94

3.53

1.2

1.1

—

Paralytic ileus

2.34

3.51

1.1

—

Malignant neoplasm of thyroid gland

172

1.99

3.49

1.2

1.1

—

Allergic urticaria

193

1.93

3.47

1.1

—

Other and unspecified disorders of skin and subcutaneous tissue

159

2.03

3.45

1.1

—

Respiratory tuberculosis, confirmed

3.02

3.42

1.4

1.1

—

ILD medications: pirfenidone

4.17

3.42

1.0

—

u/ml

—

Oesophagitis

153

2.04

3.41

1.2

1.1

—

u/ml

—

Nonspecific lymphadenitis

140

2.08

3.37

1.1

1.3

—

L01XX Other antineoplastic agents

161

2.00

3.35

1.2

1.1

—

Other and unspecified acquired haemolytic anaemias

4.45

3.33

1.3

1.1

—

Guillain-Barre syndrome

3.47

3.33

1.1

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

2.38

3.32

1.5

1.1

—

u/ml

—

Other and unspecified iridocyclitis

108

2.24

3.32

1.2

1.1

—

Special screening examination for other diseases and disorders

276

1.74

3.32

1.2

1.1

—

Other general symptoms and signs

2.49

3.31

1.1

—

Behavioural disorders

2.95

3.31

1.0

1.2

—

Other and unspecified mononeuropathies, also in other diseases

2.56

3.30

1.0

1.1

—

Optic neuritis

2.31

3.27

1.2

—

Alcoholic gastritis

3.07

3.27

1.0

1.1

—

Other abnormal findings in urine

3.07

3.27

1.4

1.0

—

Raynaud syndrome

205

1.86

3.25

1.1

1.2

—

Postzoster neuralgia

3.39

3.24

1.7

1.1

—

Vitamin D deficiency

3.38

3.23

1.2

—

Lung transplant status

4.29

3.23

1.2

1.1

—

u/ml

—

Lung transplantation

4.29

3.23

1.2

1.1

—

u/ml

—

Polycystic kidney disease

2.53

3.22

1.0

1.1

—

Mantle cell lymphoma, including Hilmo

3.59

3.21

1.0

1.4

—

Hypertension, Pulmonary Arterial

5.44

3.21

1.1

1.0

—

Benign neoplasm: Adrenal gland

221

1.82

3.19

1.1

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

117

2.16

3.17

1.1

1.2

—

Other abnormal findings of blood chemistry

111

2.18

3.13

1.0

1.2

—

Benign neoplasm of eye and adnexa

282

1.71

3.11

1.5

1.1

—

Other disorders of nervous system

187

1.88

3.10

1.1

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

7.86

3.09

1.0

1.1

—

Progressive systemic sclerosis

7.73

3.08

4.3

1.1

—

Benign neoplasm: Small intestine

112

2.16

3.07

1.0

1.2

—

Malnutrition

2.71

3.07

1.1

1.2

—

u/ml

—

Corticotropin deficiency

5.10

3.07

1.1

—

Drug-induced polyneuropathy

5.10

3.07

1.0

1.1

—

Dermatopolymyositis, unspecified

6.01

3.05

1.0

1.1

—

Secondary thrombocytopenia

3.40

3.04

1.1

—

Other crystal arthropathies

2.92

3.04

1.0

1.1

—

Artificial joint re-operation

203

1.83

3.03

1.3

1.1

—

Cytomegaloviral pneumonitis

10.71

3.03

1.2

—

Open wound of abdomen, lower back and pelvis

2.32

3.01

1.2

1.1

—

Lichenoid drug reaction

10.44

3.01

1.0

1.2

—

L01XE Protein kinase inhibitors

161

1.94

3.00

1.0

1.1

—

Tuberculosis, wide

211

1.81

3.00

1.3

1.1

—

u/ml

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.78

3.00

1.4

1.1

—

Other acute viral hepatitis

3.90

2.99

1.1

1.0

—

Neovascular glaucoma

120

2.10

2.99

1.3

1.1

—

Disorders of optic nerve, not elsewhere classified

2.66

2.98

1.1

—

Hyphaema and other vascular disorders of iris and ciliary body

2.66

2.98

1.1

—

Benign neoplasm: Duodenum

2.49

2.97

1.1

1.2

—

Acute alcohol intoxication ICD-9

2.29

2.94

1.1

1.2

—

Crystal arthropathies, rheuma endpoint

2.86

2.93

1.0

—

Listeriosis

5.56

2.90

1.0

—

u/ml

—

Other disorders of amino-acid metabolism

6.86

2.89

1.2

1.1

—

Other/unspecified mastoiditis and related conditions

6.84

2.89

1.2

1.1

—

Background retinopathy and retinal vascular changes

2.62

2.88

1.3

1.1

—

Oligomenorrhoea

2.60

2.87

1.2

1.8

—

Car occupant injured in noncollision transport accident

2.26

2.87

1.2

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

164

1.90

2.85

1.1

1.2

—

Any event in cancer register

414

2051

1.19

2.84

1.1

1.3

—

32.42

u/ml

—

Myeloproliferative diseases (CML excluded)

215

1.78

2.84

1.1

—

Complications peculiar to reattachment and amputation

4.55

2.82

1.1

1.0

—

Papillary adenocarcinoma of thyroid gland

123

2.05

2.82

1.3

1.1

—

Pyoderma gangrenosum

4.54

2.81

1.0

1.1

—

Exclusion endpoint for clefts

2.67

2.79

1.1

1.4

—

Disorders of orbit

110

2.11

2.79

1.2

1.1

—

Panniculitis, unspecified

3.98

2.79

1.0

1.1

—

Family history of certain disabilities and chronic diseases leading to disablement

2.27

2.77

1.2

1.1

—

Tick-borne viral encephalitis

8.55

2.77

1.0

—

ILD medications: nintedanib

5.14

2.75

1.1

—

Disorders of pituitary gland, other and/or unspecified

6.13

2.71

1.2

1.1

—

Glaucoma secondary to other eye disorders

125

2.02

2.71

1.3

1.2

—

Other secondary gonarthrosis

146

1.93

2.70

1.1

—

Diseases of pulp and periapical tissues and dental caries

328

1388

1.21

2.70

1.2

1.3

—

56.20

u/ml

—

Personal history of certain other diseases

3.48

2.70

1.3

1.1

—

Myelodysplastic syndrome

3.81

2.68

1.3

1.5

—

u/ml

—

Pedestrian injured in other and unspecified transport accidents

3.80

2.68

1.2

1.0

—

u/ml

—

Lesion of radial nerve

2.29

2.68

1.1

—

Molar incisor enamel hypoplasia, with caries

4.27

2.68

1.5

1.9

—

Other specified and unspecified retinal disorders

2.19

2.68

1.2

—

u/ml

—

Acute myeloid leukaemia and myelodysplastic syndromes

2.82

2.65

1.5

1.3

—

u/ml

—

Thyroiditis

169

1.84

2.62

1.1

—

Benign neoplasm of urinary organs

120

2.01

2.61

1.0

1.1

—

Hypermobility syndrome

2.26

2.60

1.1

—

u/ml

—

Umbilical hernia

124

926

1.34

2.60

1.2

—

u/ml

—

Hepatomegaly and splenomegaly, not elsewhere classified

3.66

2.59

1.1

1.2

—

Cholecystectomy

312

2240

1.20

2.59

1.1

1.3

—

38.80

u/ml

—

Renal cell carcinoma of kidney

2.20

2.58

1.1

—

u/ml

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

5.63

2.57

1.2

1.0

—

Implicit parasitic Sepsis

7.31

2.56

1.0

1.1

—

Other disorders of carbohydrate metabolism

5.60

2.56

1.2

1.0

—

Implicit parasitic Sepsis

7.28

2.56

1.0

1.1

—

Disorders of other and unspecified cranial nerves

5.59

2.56

1.0

1.1

—

Morphin

2.75

2.55

1.0

—

u/ml

—

Dermatographic urticaria

142

1.91

2.55

1.1

—

Radial styloid tenosynovitis [de Quervain]

115

2.01

2.51

1.1

1.4

—

Benign neoplasm: Choroid

172

1.81

2.50

1.2

1.1

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.28

2.49

1.5

1.2

—

Other and unspecified vaccines and biological substances

4.47

2.49

1.3

1.1

—

Anankastic personality disorder

2.21

2.47

1.3

1.1

—

Peptic ulcer

3.87

2.47

1.0

1.1

—

Carrier of infectious disease

2.48

2.45

1.1

—

Haemorrhagic disorder due to circulating anticoagulants

2.94

2.43

1.0

1.1

—

Malignant neoplasm of bladder

211

1.71

2.42

1.0

1.1

—

Other and unspecified epidermal thickening

2.31

2.42

1.3

1.2

—

u/ml

—

Malignant neoplasm of renal pelvis

5.11

2.42

4.2

1.1

—

Other/unspecified crystal arthropathies

5.11

2.42

1.0

1.2

—

Degenerative macular diseases

344

1.55

2.39

1.3

1.1

—

u/ml

—

Drug-induced gout

6.41

2.39

1.0

—

Tick-borne viral encephalitis

6.39

2.38

1.0

—

Early lumbar disc prolapse, operated

212

1.70

2.38

1.0

1.3

—

Disorders of synovium and tendon in diseases classified elsewhere

2.44

2.38

1.4

1.1

—

Protein-energy malnutrition of moderate and mild degree

4.18

2.37

1.1

—

u/ml

—

Benign neoplasm: Rectum/anal canal icd-9

4.18

2.37

1.3

1.1

—

Other specified congenital malformation syndromes affecting multiple systems

2.64

2.36

1.1

1.4

—

Cutaneous lupus erythematosus

2.52

2.36

1.0

—

Vasomotor rhinitis (mode)

191

1.74

2.33

1.0

1.1

—

Heterophoria

191

1.73

2.33

1.8

1.4

—

u/ml

—

Abnormal blood-pressure reading, without diagnosis

2.10

2.33

1.2

1.1

—

Anorexia

3.25

2.31

3.3

1.1

—

Viral meningitis

2.19

2.31

1.0

1.1

—

Other specified/unspecified soft tissue disorders

105

2.01

2.31

1.0

1.2

—

Lack of expected normal physiological development

4.10

2.30

2.4

1.5

—

Acquired pure red cell aplasia [erythroblastopenia]

4.75

2.29

1.0

1.1

—

Abnormal reflex

4.73

2.29

1.0

1.1

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

2.78

2.28

1.1

—

Benign neoplasm: Tongue

2.24

2.28

1.1

—

u/ml

—

Hyperaldosteronism

2.24

2.28

1.0

1.1

—

Other and unspecified mononeuropathies of upper limb

2.24

2.28

1.2

1.1

—

Sixth [abducent] nerve palsy

2.08

2.27

1.1

1.2

—

Other salmonella infections

2.08

2.27

1.1

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

146

1.83

2.26

1.0

1.2

—

Other arterial embolism and thrombosis

2.17

2.25

1.2

—

Other and unspecified mononeuropathies of lower limb

2.29

2.25

1.2

1.1

—

Congenital malformations of eye, ear, face and neck

149

1.82

2.24

1.0

1.2

—

u/ml

—

Other primary thrombocytopenia

5.71

2.23

1.4

1.1

—

Disorders of adrenal gland, other and/or unspecified

5.67

2.22

1.4

1.1

—

Intracranial and intraspinal abscess and granuloma

2.90

2.22

1.0

1.1

—

u/ml

—

Follow-up examination after treatment for malignant neoplasms

279

1.58

2.22

1.5

1.1

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

399

1.48

2.20

1.1

1.2

—

Intestinal adhesions without obstruction

233

1.64

2.19

1.1

—

Evidence of alcohol involvement determined by level of intoxication

3.38

2.19

1.4

1.0

—

Injury of intra-abdominal organs

2.26

2.18

1.1

—

Subacute thyroiditis

2.25

2.18

1.1

—

Use of donepezil

646

0.65

2.17

1.1

—

Unspecified protein-energy malnutrition

4.38

2.16

1.2

1.1

—

Ankylosing spondylitis

234

1.63

2.16

1.2

—

Other and unspecified nonscarring hair loss

4.36

2.16

1.7

1.1

—

Respiratory tuberculosis, clinically confirmed

3.04

2.15

1.2

1.1

—

u/ml

—

Amblyopia ex anopsia

108

1.96

2.15

1.0

1.2

—

u/ml

—

Other mycoses, not elsewhere classified/unspecified

2.65

2.15

1.4

1.1

—

Golimumab

2.18

2.15

1.0

1.2

—

Xerosis cutis

2.81

2.14

1.7

1.1

—

6-mercaptopurine

2.38

2.12

1.2

1.1

—

Fall involving bed

2.06

2.12

1.8

1.2

—

Other specified/unspecified spondylopathies

2.22

2.11

1.2

—

Other symptoms and signs involving general sensations and perceptions

102

1.97

2.10

1.0

1.1

—

Type 1 diabetes, definitions combined

212

1.65

2.10

1.0

1.4

—

Livedoid vasculitis

5.14

2.09

1.0

1.1

—

conjunctival haemorrhage

221

1.64

2.09

1.7

1.1

—

Other proliferative retinopathy

5.11

2.08

1.0

—

Nosocomial condition (hospital)

5.09

2.08

1.0

—

Volvulus

2.27

2.08

1.0

1.1

—

Mature T/NK-cell lymphomas, hilmo

2.74

2.08

1.4

1.1

—

Thyroiditis, unspecified

2.93

2.08

1.1

—

Personal history of malignant neoplasm

146

1.79

2.06

1.1

1.3

—

Other disorders of pigmentation

110

1.92

2.06

1.0

1.2

—

Cardiomyopathy in other diseases

4.09

2.05

1.2

1.0

—

Disorders of parathyroid gland, other and/or unspecified

4.07

2.05

1.0

1.1

—

Anuria and oliguria

4.07

2.05

1.3

1.1

—

Other and unspecified disorders of pigmentation

4.06

2.05

1.0

1.1

—

Other and unspecified injuries of forearm

4.06

2.05

1.8

1.1

—

Type 1 diabetes, strict (exclude DM2)

214

1.64

2.04

1.0

1.4

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

2.42

2.03

1.4

1.1

—

Clear cell adenocarcinoma of kidney

125

1.85

2.03

1.9

1.2

—

Encephalopathy

3.12

2.02

1.5

1.1

—

Type 1 diabetes, strict definition, subgroup 1

154

1.75

2.02

1.0

1.5

—

3.11

2.02

1.0

—

Congenital musculoskeletal deformities of head, face, spine and chest

3.11

2.02

1.0

1.6

—

Benign neoplasm: Rectosigmoid junction

111

1.90

2.01

1.1

1.2

—

Herpesviral keratitis and keratoconjunctivitis

1.97

2.00

1.2

—

u/ml

—

Sacroiliitis, not elsewhere classified

1.97

2.00

1.3

1.2

—

Retinal haemorrhage

2.16

1.99

1.1

—

Campylobacter enteritis

2.16

1.99

1.0

1.1

—

Polymyositis

3.39

1.97

1.0

1.1

—

Absence of one kidney

4.70

1.96

1.4

1.1

—

Malignant neoplasm of adrenal gland

4.66

1.95

1.0

—

Other and unspecified disorders of orbit

4.64

1.95

1.2

—

Central retinal artery occlusion

2.21

1.95

1.1

1.2

—

Acquired clawhand, clubhand, clawfoot and clubfoot

3.83

1.95

1.0

1.1

—

Autoimmune hepatitis

4.60

1.95

1.0

—

Other and unspecified aplastic anaemias

3.00

1.94

1.0

1.1

—

Systemic sclerosis,strict definition

3.80

1.94

1.0

1.1

—

Congenital musculoskeletal deformities of head, face, spine and chest

2.99

1.94

1.0

1.6

—

Other and unspecified haemorrhagic conditions

2.47

1.94

1.3

1.0

—

u/ml

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

113

1.87

1.92

1.4

1.2

—

Postprocedural musculoskeletal disorders, not elsewhere classified

211

1.62

1.91

1.3

1.1

—

Papilloedema, unspecified

2.26

1.91

1.2

1.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.06

1.91

1.0

1.2

—

Traction detachment of retina

3.23

1.89

1.0

—

Other nonscarring hair loss

3.22

1.89

1.6

1.1

—

Unspecified threat to breathing

3.22

1.89

1.0

1.4

—

Secondary polycythaemia

2.17

1.88

1.0

1.1

—

u/ml

—

Personal history of allergy to drugs, medicaments and biological substances

3.22

1.88

1.0

—

Enteropathic arthropathies

2.32

1.88

1.1

—

Hypoplasia of dental enamel , including avohilmo

2.17

1.88

1.8

1.3

—

Right hemicolectomy

166

1.70

1.87

1.1

—

u/ml

—

Cauda equina syndrome

2.68

1.87

1.1

—

Malignant neoplasm of other and unspecified parts of biliary tract

2.67

1.87

1.0

1.4

—

Thiamine deficiency

3.60

1.85

1.2

1.1

—

Other peripheral vascular diseases

213

1.60

1.85

1.1

1.2

—

Malignant neoplasm of adrenal gland, including Hilmo

3.59

1.85

1.0

—

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

3.58

1.85

4.0

1.1

—

Mitochondrial myopathy

4.27

1.84

1.0

1.1

—

Other infiltrative disorders of skin and subcutaneous tissue

4.26

1.83

1.4

1.1

—

Necrotizing fasciitis

4.25

1.83

1.4

1.2

—

u/ml

—

Felty syndrome

4.24

1.83

1.2

1.1

—

Melanocytic naevi, other sites/unspecified

198

1.62

1.83

1.1

1.3

—

u/ml

—

Vascular dementia

244

1.55

1.82

1.1

—

u/ml

—

Faecal incontinence

222

1.58

1.81

1.1

—

Other autoimmune haemolytic anaemias

2.60

1.81

1.0

1.1

—

Abnormal findings on diagnostic imaging of central nervous system

101

1.89

1.81

2.6

1.1

—

Donors of organs and tissues

2.60

1.80

1.0

1.1

—

Exophthalmic conditions

3.08

1.80

1.1

1.0

—

Myeloid leukaemia

2.02

1.80

1.3

1.1

—

Squamous cell neoplasms and carcinomas of the skin

254

1.54

1.80

1.1

—

Other nutritional anaemias

3.08

1.80

1.0

1.1

—

Complications following infusion, transfusion and therapeutic injection

2.37

1.78

1.2

1.1

—

Melanocytic naevi of upper limb, including shoulder

2.18

1.78

1.1

1.2

—

Alzheimer’s disease, strict definition

714

0.73

1.77

1.1

—

u/ml

—

Other and unspecified abdominal hernia

109

1.85

1.77

2.3

1.1

—

Perforation of tympanic membrane

280

1.50

1.76

1.6

1.1

—

u/ml

—

Lichen simplex chronicus and prurigo

177

1.65

1.76

1.2

1.1

—

u/ml

—

Other anxiety disorders

166

1178

1.22

1.75

1.1

1.3

—

38.90

—

Alzheimer’s disease (Late onset)

668

0.72

1.74

1.1

—

u/ml

—

Congenital malformations of uterus and cervix

2.52

1.74

1.2

1.1

—

Mantle cell lymphoma

2.96

1.73

1.0

1.5

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.70

1.73

1.1

—

Benign neoplasm: Skin of lip

2.69

1.73

1.0

1.1

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

178

1.63

1.72

1.1

—

u/ml

—

Pleural plaque with presence of asbestos

258

1.52

1.71

1.4

1.1

—

u/ml

—

Other and unspecified diseases of blood and blood-forming organs

2.07

1.70

1.3

1.2

—

Hodgkin lymphoma, hilmo

1.97

1.70

1.8

1.2

—

Hyperkinetic disorders (excl. ADHD)

0.00

1.69

0.0

1.4

—

Other salmonella infections

111

1.81

1.69

1.1

1.2

—

Type 1 diabetes, strict definition

171

1.64

1.68

1.0

1.5

—

Spondylopathies in diseases classified elsewhere

2.53

1.67

2.2

1.2

—

Use of rivastigmine

466

0.64

1.67

1.2

1.1

—

Motor neuron disease

2.52

1.67

1.1

—

Other and unspecified injuries of neck

3.20

1.67

1.0

1.1

—

u/ml

—

Tarsal tunnel syndrome

3.19

1.66

1.0

1.1

—

Combined immunodeficiencies

3.19

1.66

1.0

1.1

—

Malignant neoplasm of mesothelium and soft tissue

1.87

1.66

1.0

1.2

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

134

1.72

1.66

1.1

—

Paraplegia, diplegia of upper limbs

2.11

1.66

1.1

—

u/ml

—

IBD (strict) with PSC

2.83

1.65

1.7

1.1

—

Fasciculation

2.83

1.65

1.0

1.1

—

Gluteal tendinitis

1.90

1.65

1.1

1.2

—

Acute posthaemorrhagic anaemia

1.98

1.64

1.2

—

Female infertility, associated with anovulation

112

1.79

1.64

1.1

1.5

—

Benign neoplasm: Stomach

285

1.48

1.64

1.1

—

Birth asphyxia

3.63

1.62

1.0

1.7

—

Hand

3.63

1.62

1.2

1.1

—

Unspecified event, undetermined intent

2.08

1.60

1.0

1.2

—

Inflammatory disease of uterus

303

1.46

1.60

1.1

1.2

—

u/ml

—

Benign neoplasm: other/unspecified salivary gland

2.01

1.59

1.1

—

Other diseases of spinal cord

1.96

1.59

1.0

1.1

—

Follow-up care involving plastic surgery

2.01

1.59

1.0

—

Motor neuron disease (with DMD)

2.34

1.59

1.1

—

Viral conjunctivitis

2.34

1.59

1.1

—

Fibrosis of liver

3.05

1.59

1.0

1.1

—

Seminoma of testis, including Hilmo

2.72

1.59

1.0

1.5

—

Sequelae of tuberculosis

2.29

1.56

1.2

1.0

—

u/ml

—

Disorder of external ear, unspecified

1.89

1.55

1.1

—

Cerebral cysts

137

1.69

1.55

1.3

1.2

—

Other specified/unspecified disorders of bone/cartilage

1.94

1.54

1.1

—

Congenital malformations of breast

2.44

1.54

1.0

1.3

—

Congenital malformations of breast

2.44

1.54

1.0

1.3

—

Renal agenesis and other reduction defects of kidney

3.39

1.53

1.4

1.1

—

Sequelae of intentional self-harm, assault and events of undetermined intent

3.38

1.53

1.0

—

Migraine, unspecified, drug-induced

3.38

1.53

1.2

1.1

—

Myotonic disorders

3.37

1.53

1.6

1.1

—

Benign neoplasm of other and unspecified intrathoracic organs

2.62

1.52

1.0

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.61

1.52

1.1

1.3

—

Endometriosis of rectovaginal septum and vagina

169

1.60

1.51

1.3

1.4

—

Chronic myeloid leukaemia, including Hilmo

2.89

1.51

1.0

1.1

—

Migraine with aura, drug-induced

2.88

1.51

1.2

1.1

—

Postmenopausal atrophic vaginitis

429

0.73

1.51

1.1

1.2

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

108

1.77

1.51

1.6

1.2

—

Unknown and unspecified causes of morbidity

123

1.71

1.50

1.1

1.0

—

Fracture of forearm

220

1724

1.17

1.50

1.3

—

42.14

u/ml

—

Use of selegiline

128

0.39

1.49

1.0

1.2

—

Postprocedural disorders of digestive system, not elsewhere classified

1.95

1.49

1.1

—

Somnolence, stupor and coma

116

1.73

1.49

1.1

—

Pustulosis palmaris et plantaris

1.82

1.47

1.3

1.1

—

Open wound of thorax

2.24

1.47

1.6

1.1

—

Polycythaemia vera

1.85

1.46

1.1

1.2

—

Other acute skin changes due to ultraviolet radiation

1.85

1.46

1.0

1.2

—

u/ml

—

Other erythematous conditions

1.85

1.46

1.1

—

u/ml

—

Other benign neoplasms of connective and other soft tissue

268

1.46

1.2

1.1

—

Torsion of ovary, ovarian pedicle and fallopian tube

2.38

1.46

1.3

2.0

—

Occlusion and stenosis of arteries, not leading to stroke

2.52

1.45

1.0

—

Complications of labour and delivery

148

993

0.83

1.45

1.3

1.4

—

25.58

u/ml

—

Other and unspecified erythematous conditions

1.89

1.45

1.1

—

u/ml

—

Ulcerative enterocolitis

1.89

1.45

1.1

—

Lesion of plantar nerve

140

1.65

1.45

1.1

—

Acute hepatitis B

3.19

1.45

1.0

1.1

—

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

3.16

1.44

1.0

1.7

—

Hepatocellular carcinoma

2.05

1.44

1.2

1.3

—

Diseases caused by chlamydiae

2.75

1.44

4.7

1.1

—

Prurigo nodularis

2.05

1.44

1.0

1.1

—

Left hemicolectomy

1.98

1.44

1.2

1.1

—

Benign neoplasm: Other and unspecified parts of small intestine

2.33

1.43

1.0

1.1

—

Contusion of ankle

1.83

1.41

1.1

1.2

—

Other disorders of central nervous system

2.43

1.39

2.0

1.1

—

Family history of other conditions

2.43

1.39

1.0

1.3

—

Foreign body in respiratory tract

134

1.65

1.39

1.0

1.1

—

Non-allergic asthma

238

1.47

1.38

1.8

1.1

—

u/ml

—

Seminoma of testis

2.64

1.37

1.0

1.5

—

Benign neoplasm: Bladder

2.63

1.37

1.0

1.1

—

Respiratory tuberculosis, not confirmed

104

1.74

1.37

1.2

—

u/ml

—

Bus occupant injured in other and unspecified transport accidents

2.98

1.36

1.0

1.1

—

Disorder of pancreatic internal secretion, other and/or unspecified

2.98

1.36

1.2

1.1

—

Acute myringitis

2.98

1.36

1.0

1.1

—

Presence of other devices

729

1.26

1.36

1.2

—

Endometriosis of pelvic peritoneum

356

1.37

1.35

1.1

1.2

—

Carcinoma in situ of skin of other and unspecified parts of face

248

1.46

1.35

1.2

1.1

—

u/ml

—

Contact with sharp glass

1.76

1.35

1.3

1.2

—

u/ml

—

Dissociative [conversion] disorders

1.87

1.34

1.0

1.2

—

Assault by sharp object

2.14

1.34

1.4

1.1

—

Use of amantadine

0.00

1.34

0.0

1.1

—

Dissection of aorta

1.79

1.33

1.2

—

Degeneration of the brain due to alcohol

1.98

1.33

1.1

1.3

—

Other noninflammatory disorders of vagina

168

1.55

1.31

1.1

1.3

—

Benign neoplasm: Nasopharynx

2.53

1.31

1.2

1.1

—

Osteonecrosis due to drugs

2.11

1.31

1.2

1.1

—

Other diseases caused by chlamydiae

2.52

1.31

4.7

1.1

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.85

1.30

1.0

1.2

—

Dementia in Alzheimer disease

490

0.72

1.30

1.1

—

u/ml

—

Other chondrocalcinosis

2.38

1.29

1.0

1.1

—

Chronic myeloproliferative disease

2.38

1.29

1.1

—

Benign neoplasm: Bronchus and lung

2.38

1.29

1.0

1.1

—

Benign neoplasm: Skin of trunk

106

1.71

1.29

1.2

—

Disorders of iron metabolism

2.37

1.29

1.3

1.1

—

Drug-induced tremor

2.82

1.29

1.0

1.1

—

Other/unspecified enthesopathies of lower limb, excluding foot

169

1.54

1.28

1.3

1.1

—

Drug-induced hypoglycaemia without coma

2.10

1.28

1.0

1.1

—

Rheumatic valve diseases

2.01

1.27

1.1

—

Injury of unspecified body region

210

1.48

1.27

1.1

—

Colitis, primary sclerosing

2.30

1.27

1.6

1.1

—

Abscess of external ear

2.30

1.27

1.0

1.1

—

Injuries involving multiple body regions

1.75

1.25

1.1

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

2.42

1.25

1.0

1.1

—

Liposarcoma, including Hilmo

2.42

1.25

1.0

—

Pigmented purpuric dermatosis

2.42

1.25

1.0

1.1

—

Other and unspecified bullous disorders

2.42

1.25

1.2

1.0

—

Post-traumatic wound infection, not elsewhere classified

1.87

1.24

1.1

—

Hyperhidrosis

2.01

1.23

1.0

1.1

—

Degeneration of nervous system due to alcohol

1.92

1.23

1.1

1.3

—

Unspecified urinary incontinence

220

1.46

1.23

1.1

—

u/ml

—

Lichen simplex chronicus

1.77

1.23

1.3

1.1

—

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

139

1.59

1.23

1.1

1.4

—

u/ml

—

Heart failure and hypertrophic cardiomyopathy

2.06

1.22

1.0

1.1

—

Retinal detachment with retinal break

399

1.33

1.21

1.2

1.1

—

u/ml

—

Benign neoplasm: Anus and anal canal

1.80

1.21

1.3

1.1

—

Corneal scars and opacities

1.84

1.19

1.3

1.1

—

Vulvovaginal ulceration/inflammation in other diseases

101

1.69

1.19

1.1

1.5

—

Other menopausal disorders

439

0.77

1.19

1.2

—

Benign neoplasm: Vagina

2.32

1.19

1.3

1.1

—

Family history of other specific disorders

2.32

1.19

1.2

1.1

—

Disorders in reading

2.12

1.18

1.1

1.3

—

Retinoschisis and retinal cysts

1.89

1.18

1.1

—

Congenital malformations of genital organs

188

1.48

1.18

1.2

1.3

—

Malignant neoplasm of other connective and soft tissue

1.94

1.17

1.0

1.2

—

Viral conjunctivitis

1.78

1.17

1.1

—

Dementia in other diseases classified elsewhere

129

0.46

1.16

1.2

1.1

—

Malignant neoplasm of parotid gland

2.53

1.15

1.0

1.1

—

Other deformity of hallux (acquired)

2.52

1.15

1.2

1.1

—

Blood alcohol or alcohol intoxication level

1.86

1.13

1.3

1.1

—

Vascular dementia (subcortical)

1.76

1.13

1.0

1.2

—

Localized scleroderma [morphea]

2.35

1.12

1.0

1.3

—

LSIL lesion of the vagina

2.35

1.12

1.3

1.1

—

Universal erythroderma, KELA reimbursement

2.01

1.12

1.0

1.1

—

Carcinoma in situ of skin

250

1.40

1.12

1.2

1.1

—

u/ml

—

Postpartum hemorraghe, parous women as controls

441

0.73

1.12

1.1

1.2

—

Malignant neoplasm of eye, brain and central nervous system

115

0.43

1.11

1.2

—

Ovarian cyst

117

561

1.20

1.11

1.1

1.2

—

Appendectomy

258

2191

1.13

1.11

1.4

1.3

—

49.07

u/ml

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

135

1.56

1.11

1.0

1.2

—

Muscle strain

1.79

1.11

1.1

1.2

—

Arthropathy in ulcerative colitis

2.28

1.10

1.1

—

Family history of malignant neoplasm

234

1.41

1.10

1.1

1.3

—

Fracture of neck

176

1.48

1.10

1.1

—

u/ml

—

Cholesteatoma of external ear

2.41

1.09

1.0

1.1

—

u/ml

—

Personal history of medical treatment

2.40

1.09

1.2

1.1

—

Other diseases of gallbladder

104

1.64

1.09

1.5

1.0

—

u/ml

—

Inflammatory disorders of breast

120

1.59

1.08

1.2

1.1

—

Diseases caused by chlamydiae

2.20

1.08

4.1

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

128

1079

1.18

1.08

1.1

1.4

—

44.30

—

therapeutic use

1.69

1.08

1.3

1.1

—

Postpartum haemorrhage due to anatomy

165

0.54

1.07

1.3

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

1.88

1.07

1.1

—

Other specified/unspecified bacterial intestinal infections

177

1.47

1.07

1.1

1.2

—

Other and unspecified disease of Bartholin gland

1.87

1.07

1.2

1.0

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.77

1.07

1.0

1.1

—

Essential (haemorrhagic) thrombocythaemia

1.66

1.07

1.1

1.2

—

Diseases of spleen

1.94

1.06

1.5

1.1

—

Parkinson's disease, including avohilmo

523

0.74

1.06

1.0

1.1

—

u/ml

—

Malignant neoplasm of heart, mediastinum and pleura

2.14

1.06

1.0

1.4

—

2.13

1.05

1.3

1.5

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.13

1.05

3.7

1.0

—

All dysplastic lesions of the vulva

1.71

1.05

1.2

1.4

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.80

1.05

1.0

1.2

—

u/ml

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.80

1.05

1.1

—

Use of levodopa decarboxylase inhibitor

453

0.73

1.04

1.1

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

1.97

1.04

1.0

1.3

—

Malignant neoplasm of ureter, including Hilmo

2.29

1.04

4.8

1.5

—

Diastasis of muscle

2.29

1.03

1.0

1.1

—

Diabetes insipidus

2.29

1.03

1.8

1.1

—

Other papulosquamous disorders

2.29

1.03

1.0

1.4

—

Endovascular or surgical operations to intracerebral aneurysms

149

0.54

1.03

1.0

1.1

—

Other injuries of upper limb, level unspecified

2.07

1.03

1.0

1.3

—

Other disorders of optic disc

2.07

1.03

1.3

1.1

—

Dislocation of lens

2.07

1.03

1.0

1.4

—

Other diseases caused by chlamydiae

2.07

1.03

4.1

1.1

—

Fistulae involving female genital tract

2.07

1.03

1.0

1.1

—

Carcinoma in situ of other and unspecified sites

114

1.59

1.03

2.1

1.2

—

u/ml

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

1.93

1.02

1.0

1.4

—

All dysplastic lesions of the vagina

1.92

1.02

1.2

1.1

—

Oesophageal obstruction

1.66

1.00

1.1

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.88

1.00

1.6

1.3

—

Embolic stroke with flimmer

1.77

1.00

1.1

1.2

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS